Filing Details
- Accession Number:
- 0001104659-19-033437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-03 16:00:34
- Reporting Period:
- 2019-05-30
- Accepted Time:
- 2019-06-03 16:00:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615726 | H.t. Leonardus Ploeg Der Van | 222 Berkeley Street, Suite 1200 Boston MA 02116 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-30 | 5,000 | $4.59 | 47,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-30 | 5,000 | $25.31 | 42,339 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 5,000 | $4.59 | 47,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-31 | 5,000 | $25.10 | 42,339 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2019-05-30 | 5,000 | $0.00 | 5,000 | $4.59 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2019-05-31 | 5,000 | $0.00 | 5,000 | $4.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,611 | 2025-11-16 | No | 4 | M | Direct | |
| 8,611 | 2025-11-16 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $25.11 to $25.64, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.00 to $25.33, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
Billionaire Hedge Funds
